|Swedish Orphan Biovitrum AB -- USA Stock|| |
USD 14.72 0.0005 0.0034%
Vice President - Communications for North America
Ms. Trista Morrison is Vice President Communications for North America of the Company. Morrison more than 15 years in biopharmaceutical communications span corporate, reporter and agency roles. Most recently, Morrison served as director of corporate communications for Ironwood Pharmaceuticals, where she led internal, external and brand communications as the company transitioned from a research and development organization to a fully integrated commercial biotechnology company. Prior to her role at Ironwood, Morrison served as an editor and staff writer at BioWorld Today, covering breaking news and trends in the biopharmaceutical industry. Previously she served in various positions with biopharmaceuticalfocused public relations agency Porter Novelli Life Sciences . Morrison was honored as one of PR News Top Women in PR in 2017, which recognizes communicators who have made bold advances in the profession.
President Since 2017
46 86 97 20 00 http://www.sobi.com
The company has return on total asset (ROA)
of 6.58 %
which means that it generated profit of $6.58 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 14.88 %
meaning that it generated $14.88 on every $100 dollars invested by stockholders.
The company has accumulated 60.96 M in total debt with debt to equity ratio (D/E) of 7.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Swedish Orphan Biovitrum AB has Current Ratio of 1.78 which is within standard range for the sector.
Swedish Orphan Biovitrum AB , an integrated biopharmaceutical company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetics and metabolism diseases primarily in Europe and North America. Swedish Orphan Biovitrum AB (BIOVF) is traded on OTC Market in USA. It is located in Stockholm, and employs 758 people.